Kewaunee Scientific (KEQU) AI Stock Analysis

• Market Cap: $97.49M
• Dividend Yield: N/A
• Average Volume (3M): 8.77K
• Price to Earnings (P/E): 40.9
• Beta (1Y): 0.73
• Revenue Growth: 43.02%
• EPS Growth: -37.24%
• Country: US
• Employees: 1,006
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Furnishings, Fixtures & Appliances
• EPS (TTM): 0.23
• Shares Outstanding: 2,866,384
• 10 Day Avg. Volume: 10,539
• 30 Day Avg. Volume: 8,774
• PEG Ratio: -0.20
• Price to Book (P/B): 1.41
• Price to Sales (P/S): 0.38
• P/FCF Ratio: 7.18
• Enterprise Value/Market Cap: 1.50
• Enterprise Value/Revenue: 0.51
• Enterprise Value/Gross Profit: 1.76
• Enterprise Value/Ebitda: 5.49
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 61 Neutral
• Price Target: $37.00 ▼(-3.52% Downside)
• Action: Reiterated Date: 03/14/26
• Date: Action: Reiterated 03/14/26

The score is driven primarily by improved financial performance (profitability rebound, strong revenue growth, and solid positive free cash flow), tempered by increased leverage. Technicals are weak with the stock below major moving averages and negative momentum, while valuation is elevated on a high P/E with no dividend support. Corporate events are modestly positive but hinge on forthcoming results.

Positive Factors

Revenue growth & profitability rebound

Sustained ~78% TTM revenue growth and return to profitability reflect durable demand for lab build-outs and strong project execution. Over 2–6 months this expands operating leverage, supports reinvestment in production and sales, and strengthens the firm's ability to fund growth without relying solely on external capital.

Negative Factors

Rising leverage

Higher debt levels reduce financial flexibility and elevate refinancing and interest-rate risk if project volumes slow. For a project-driven business, increased leverage constrains the firm's ability to bid aggressively, invest in capacity, or absorb delays in receivables without eroding liquidity.

Kewaunee Scientific Business Overview & Revenue Model

Company Description

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates through two segments, Domestic and International. The company's products include steel, wo...

Read more

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates through two segments, Domestic and International. The company's products include steel, wo...

How the Company Makes Money

Kewaunee Scientific makes money primarily by selling and delivering laboratory furniture and integrated lab environments to institutional and commercial customers. Its core revenue stream is product sales (e.g., laboratory casework, benches/workst...

Read more

Kewaunee Scientific makes money primarily by selling and delivering laboratory furniture and integrated lab environments to institutional and commercial customers. Its core revenue stream is product sales (e.g., laboratory casework, benches/workst...

Kewaunee Scientific Financial Statement Overview

Breakdown	TTM	Apr 2025	Apr 2024	Apr 2023	Apr 2022	Apr 2021
Income Statement
Total Revenue	287.75M	240.47M	203.75M	219.49M	168.87M	147.47M
Gross Profit	83.23M	68.86M	52.05M	35.59M	24.22M	23.99M
EBITDA	26.69M	22.76M	18.04M	8.16M	916.00K	459.00K
Net Income	11.08M	11.40M	18.75M	1.36M	-6.00M	-3.61M
Balance Sheet
Total Assets	175.96M	194.65M	134.77M	118.90M	118.77M	89.38M
Cash, Cash Equivalents and Short-Term Investments	10.35M	14.94M	23.27M	8.08M	4.43M	5.21M
Total Debt	59.34M	50.16M	11.00M	12.92M	67.56M	16.15M
Total Liabilities	103.43M	128.41M	78.56M	80.41M	82.59M	47.90M
Stockholders Equity	70.67M	64.46M	54.76M	37.41M	35.69M	41.24M
Cash Flow
Free Cash Flow	19.05M	12.62M	15.19M	-7.94M	-9.79M	-1.49M
Operating Cash Flow	22.58M	14.78M	19.56M	-3.79M	-7.88M	912.00K
Investing Cash Flow	-3.52M	-30.90M	-4.37M	-4.15M	-1.91M	-2.40M
Financing Cash Flow	-20.71M	7.41M	-3.01M	14.93M	11.03M	1.98M

Kewaunee Scientific Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 38.35
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KEQU, the sentiment is Negative. The current price of 38.35 is above the 20-day moving average (MA) of 35.88, below the 50-day MA of 38.66, and below the 200-day MA of 44.34, indicating a bearish trend. The MACD of -1.53 indicates Positive momentum. The RSI at 33.18 is Neutral, neither overbought nor oversold. The STOCH value of 12.93 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KEQU.

Kewaunee Scientific Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
FLXS	71 Outperform	$248.89M	7.91	12.37%	1.77%	6.00%	64.58%
ETD	70 Outperform	$566.44M	12.45	9.20%	7.86%	-4.26%	―
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
KEQU	61 Neutral	$97.49M	40.94	16.29%	―	43.02%	-37.24%
HOFT	54 Neutral	$145.18M	-1.14	-15.57%	7.20%	-12.09%	-204.66%
BSET	48 Neutral	$121.23M	29.10	3.24%	4.59%	-2.74%	―
VIRC	47 Neutral	$97.09M	-21.77	3.48%	1.59%	-27.97%	-83.58%

Kewaunee Scientific Corporate Events